Combined effects of different interleukin-28B gene variants on the outcome of dual combination therapy in chronic hepatitis C virus type 1 infection
✍ Scribed by Janett Fischer; Stephan Böhm; Markus Scholz; Tobias Müller; Heiko Witt; Jacob George; Christoph Sarrazin; Simone Susser; Eckart Schott; Vijayaprakash Suppiah; David R. Booth; Graeme J. Stewart; Florian van Bömmel; Annika Brodzinski; Balazs Fülöp; Pascal Migaud; Thomas Berg
- Book ID
- 112097835
- Publisher
- John Wiley and Sons
- Year
- 2012
- Tongue
- English
- Weight
- 618 KB
- Volume
- 55
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract The interferon sensitivity‐determining region (ISDR) is useful as a predictive marker of the response to interferon (IFN) therapy for chronic hepatitis patients with a Japan‐specific subtype (J‐type) of hepatitis C virus (HCV) genotype 1b. This marker is not useful for predicting respon
## Abstract Hepatitis C virus (HCV) genotype 1a is rare in Japanese patients and the clinical characteristics of this genotype remain unclear. The interferon (IFN) sensitivity‐determining region (ISDR) and single‐nucleotide polymorphisms (SNPs) of interleukin‐28B (IL28B) among patients with HCV gen